Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced versus standard gelatin-based fluid therapy during abdominal surgery
2010-018524-58Phase 3Terminated
- Sponsor
- B. Braun
- Start
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of succinylated gelatin and gelatin (2 arms), sponsored by B. Braun. Primary endpoint: Difference in base excess and chloride from baseline to end of surgery. Started Apr 2011; status: terminated.
02
Drugs
succinylated gelatingelatin
Beyond the preview
Go deeper on 2010-018524-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018524-58.